Nimodipine Monotherapy and Carbamazepine Augmentation in Patients With Refractory Recurrent Affective Illness-Reference-Cited by-同舟云学术

Nimodipine Monotherapy and Carbamazepine Augmentation in Patients With Refractory Recurrent Affective Illness

Published:1998-10 Issue:5 Volume:18 Page:404-413
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Pazzaglia Peggy J.,Post Robert M.,Ketter Terence A.,Callahan Ann M.,Marangell Lauren B.,Frye Mark A.,George Mark S.,Kimbrell Tim A.,Leverich Gabriele S.,Cora-Locatelli Gabriela,Luckenbaugh David

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference60 articles.

1. Outcome of Bipolar Disorder on Long-Term Treatment with Lithium

2. Comparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder

3. Relapse and impairment in bipolar disorder

4. The calcium second messenger system in bipolar disorders: data supporting new research directions

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pilot pharmacogenetic study of calcium channel blocker treatment of bipolar mania;Psychiatry Research;2023-08

2. L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: Implications for substance use, mood disorders and co-morbidities;Neuropharmacology;2023-02

3. Nimodipine in treatment of bipolar disorder;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

4. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders;Molecular Psychiatry;2022-05-26

5. Calcium Channel Antagonists for Mood Disorders;Journal of Clinical Psychopharmacology;2022-02-21